Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourBullish
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns up above $1.37
Key levels
Resistance$0.33
Resistance$0.19
Latest news & SEC filings
EarningsAccendra Health posts third quarter 2026 financial results
EarningsAccendra Health holds Q3 2026 earnings call
All ACH news →Accendra Health supplies medical gear and related services for use in patients' homes across the United States. Its Apria and Byram Healthcare brands serve individuals, home health agencies, and payors such as Medicare, Medicaid, and private insurers. Offerings include diabetes care, breathing support, sleep apnea devices, and other home-use products. The company is based in Richmond, Virginia.
Based on the company's 10-K filed Feb 20, 2026.
NYSE · Healthcare
SEPT Low Target
$1.50
SEPT Mid Target
$1.50
SEPT High Target
$1.50
Analyst Consensus
$1.50
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ACH.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$1.14
32
Moat Score
NONE
2/9
Piotroski Score
0.4
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Gardner-Smith Kenneth | director officer | Buy | 283,554 | - | Oct 5, 2026 |
| Leon Jonathan A | officer | Sale | 4,265 | $4K | Sep 23, 2026 |
| Galloway Heath H | officer | Sale | 1,822 | $5K | May 18, 2026 |
| Leon Jonathan A | officer | Sale | 1,770 | $5K | May 15, 2026 |
| Pesicka Edward A | director officer | Sale | 17,692 | $54K | May 15, 2026 |
| Galloway Heath H | officer | Sale | 966 | $3K | May 15, 2026 |
| Bernocchi Perry A | officer | Sale | 7,908 | $24K | May 15, 2026 |
| Kline Teresa L. | director | Buy | 31,191 | - | May 14, 2026 |
| Klemash Stephen W | director | Buy | 31,191 | - | May 14, 2026 |
| Gardner-Smith Kenneth | director | Buy | 31,191 | - | May 14, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
3.1%
3yr Revenue CAGR
-34.8%
EPS Growth YoY
-202.54%
FCF Growth YoY
-3230.1%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for ACH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:31:56 | $0.15 | 2,000 | $$300 | BUY |
| 14:31:45 | $0.15 | 2,840 | $$418 | BUY |
| 14:31:33 | $0.14 | 4,100 | $$577 | SELL |
| 14:31:33 | $0.14 | 2,091 | $$301 | SELL |
| 14:31:33 | $0.14 | 2,187 | $$316 | SELL |
5 dark pool trades shown · $$2K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for ACCENDRA HEALTH INC/VA/ (ACH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ACCENDRA HEALTH INC/VA/ (ACH) is at $0.14, down 3.58% (-$0.01) at the Nov 12, 2026 close.
Latest ACH news — Nov 6, 2026: Accendra Health posts third quarter 2026 financial results · Nov 5, 2026: Accendra Health holds Q3 2026 earnings call
Accendra Health shares fell 2.64% to close at $0.43 after the company disclosed it received an NYSE notice for failing to meet the $1.00 minimum share price rule. The stock traded between $0.42 and $0.45 on volume of 673,909 shares.
The average analyst price target for ACH is $1.50, ranging from $2 to $2, based on 3 analysts. Latest: UBS maintains on Aug 13, 2026.
Analyst ratings for ACH: 0 Buy, 5 Hold, 2 Sell — consensus Hold.
ACH last reported on Aug 10, 2026: EPS -$0.19 vs -$0.08 expected — a miss of 126.7%.
ACH does not currently pay a dividend.
ACCENDRA HEALTH INC/VA/ reported $1.7B of debt and $8M of cash (Jun 30, 2026).
Resistance: $0.19, $0.33, $0.96.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 6, 2026: Accendra Health posts third quarter 2026 financial results · Nov 5, 2026: Accendra Health holds Q3 2026 earnings call